Item 2.01.
Completion of Acquisition or Disposition of Assets.
On July 6, 2018, Marvell Technology Group Ltd., a Bermuda exempted company (the Company), completed its previously announced acquisition of Cavium, Inc., a Delaware corporation (Cavium), pursuant to the Agreement and Plan of Merger dated as of November 19, 2017 (the Merger Agreement), by and among the Company, Kauai Acquisition Corp., a Delaware corporation and an indirect wholly owned subsidiary of the Company (Merger Sub), and Cavium. Pursuant to the Merger Agreement, Merger Sub merged with and into Cavium (the Merger), with Cavium surviving as a subsidiary of the Company.
At the effective time of the Merger (the Merger Effective Time), each share of common stock, $0.001 par value per share, of Cavium (each, a Cavium Share) issued and outstanding immediately prior to the Merger Effective Time (other than (i) Cavium Shares held by Cavium (or held in Caviums treasury) or held by the Company, Merger Sub or any other subsidiary of the Company or held, directly or indirectly, by any subsidiary of Cavium or (ii) Cavium Shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law) was automatically converted into the right to receive 2.1757 common shares, $0.002 par value per share, of the Company (each, a Marvell Share) and $40.00 in cash, without interest (such consideration, collectively, the Merger Consideration).
Also in connection with the Merger, at the Merger Effective Time:
(i) each outstanding option to purchase Cavium Shares from Cavium (each, a Cavium Option), other than a Director Option (as defined below), whether vested or unvested, was assumed by the Company and converted into an option to purchase, on the same terms and conditions as were applicable under such Cavium Option, that number of Marvell Shares equal to the product of 4.0339 and the number of Cavium Shares subject to such Cavium Option at an exercise price per Marvell Share calculated in accordance with the terms of the Merger Agreement;
each outstanding option to purchase Cavium Shares from Cavium (each, a Cavium Option), other than a Director Option (as defined below), whether vested or unvested, was assumed by the Company and converted into an option to purchase, on the same terms and conditions as were applicable under such Cavium Option, that number of Marvell Shares equal to the product of 4.0339 and the number of Cavium Shares subject to such Cavium Option at an exercise price per Marvell Share calculated in accordance with the terms of the Merger Agreement;
(ii) each outstanding Cavium Option held by non-employee members of Caviums board of directors (except for Messrs. Ali, Buss and Frank, who have been appointed to serve on Marvells board of directors (the Board) as of the Merger Effective Time) (each, a Director Option) that was vested immediately prior to the Merger Effective Time was cancelled in exchange for the right of the holder to receive an amount in cash equal to $86.83 less the applicable exercise price for each Cavium Share subject to such Director Option;
each outstanding Cavium Option held by non-employee members of Caviums board of directors (except for Messrs. Ali, Buss and Frank, who have been appointed to serve on Marvells board of directors (the Board) as of the Merger Effective Time) (each, a Director Option) that was vested immediately prior to the Merger Effective Time was cancelled in exchange for the right of the holder to receive an amount in cash equal to $86.83 less the applicable exercise price for each Cavium Share subject to such Director Option;
(iii) each outstanding restricted stock unit of Cavium (each, a Cavium RSU), other than a Director RSU (as defined below), that was unvested immediately prior to the Merger Effective Time was converted into that number of Marvell restricted stock units equal to the product of 4.0339 and the number of Cavium Shares subject to such Cavium RSU;
each outstanding restricted stock unit of Cavium (each, a Cavium RSU), other than a Director RSU (as defined below), that was unvested immediately prior to the Merger Effective Time was converted into that number of Marvell restricted stock units equal to the product of 4.0339 and the number of Cavium Shares subject to such Cavium RSU;
(iv) each outstanding Cavium RSU that was vested immediately prior to the Merger Effective Time, or that was held by any non-employee member of Caviums board of directors immediately prior to the Effective Time, whether vested or unvested (each, a Director RSU), was cancelled in exchange for the Merger Consideration for each Cavium Share subject to such Cavium RSU; and
each outstanding Cavium RSU that was vested immediately prior to the Merger Effective Time, or that was held by any non-employee member of Caviums board of directors immediately prior to the Effective Time, whether vested or unvested (each, a Director RSU), was cancelled in exchange for the Merger Consideration for each Cavium Share subject to such Cavium RSU; and
(v) each performance-based restricted stock unit of Cavium (Cavium PRSU) outstanding and unvested immediately prior to the Merger Effective Time was assumed and converted into that number of Marvell restricted stock units equal to the product of 4.0339 and the target number of Cavium Shares subject to such Cavium PRSU.
each performance-based restricted stock unit of Cavium (Cavium PRSU) outstanding and unvested immediately prior to the Merger Effective Time was assumed and converted into that number of Marvell restricted stock units equal to the product of 4.0339 and the target number of Cavium Shares subject to such Cavium PRSU.
The cash portion of the Merger Consideration described in this Item 2.01 was funded in part by a $900.0 million term loan and the issuance of $1.0 billion of senior unsecured notes, each of which is described in additional detail in the Companys Current Reports on Form 8-K as filed with the Securities and Exchange Commission (the SEC) on June 13, 2018 (for Items 1.01, 2.03 and 9.01) and June 22, 2018, which are incorporated herein by reference.
The foregoing description of the Merger Agreement and the transactions contemplated by the Merger Agreement is only a summary and is subject to, and qualified in its entirety by, reference to the full text of the Merger Agreement, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed by the Company with the SEC on November 20, 2017, and is incorporated herein by reference. The Merger Agreement has been included to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about the Company, Cavium or any of their respective subsidiaries or affiliates. The representations and warranties and the covenants in the Merger Agreement were made solely for the benefit of the parties to the Merger Agreement. Investors should not rely on the representations and warranties and the covenants as characterizations of the actual state of facts or condition of the Company, Cavium or any of their respective subsidiaries or affiliates.
